[INM] YoY Annual Result on 30-Jun-2019 [#FY]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
30-Jun-2019
Financial Year
2019
Quarter
30-Jun-2019 [#FY]
Profit Trend
YoY- -49.22%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Annual Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 1,089 0 0 0 0 0 0 -
PBT -18,600 -10,203 -8,681 -10,097 -6,708 -3,440 -1,837 47.05%
Tax 4,808 360 19 -262 -70 0 0 -
NP -18,600 -10,200 -8,940 -10,010 -6,708 -3,440 -1,837 47.05%
Tax Rate - - - - - - - -
Total Cost 19,690 10,200 8,940 10,010 6,708 3,440 1,837 48.46%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -1,707.32 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -33.17 -37.78 -42.57 -47.67 -38.85 -31.73 -25.18 4.69%
EPS Diluted -33.17 -37.78 -42.57 -47.67 -38.85 -31.73 -25.18 4.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.